U.S. markets open in 7 hours 17 minutes

Ocugen, Inc. (OCGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.3225+0.0086 (+2.74%)
At close: 4:00PM EDT
Sign in to post a message.
  • E
    Emmdizzle
    Agree with Macrocosmonaut....this stock chart looks like it's about to enter stage three...Houston, ready for liftoff!
    Bullish
  • E
    Emmdizzle
    Two important upcoming dates: October 21 ( Investor meeting with Cantor Fitzgerald and Analyst Kristen Kluska) and November 6 (Q3 Earnings release). If the big money likes what they hear then this could be big. Generally Institutional investors sell before an election because of the uncertainty of who will be president and afterward will begin buying once they know who wins. November could be a very special month for Ocugen. The chart is showing classical stage one and two patterns, so stage 3 might not be far off for tremendous gains.
  • M
    Mark Nejmeh
    Hey matt just bought another 200000 now holding 1200000 shares I am sure you are happy to know
  • M
    Mark Nejmeh
    Now holding 1000000 shares @.3277 good luck folks
  • T
    Tommy Pickles
    :( spoke too soon.
    Like I said tho
    Every spike will be backed by a few profiteers
    It's all good tho
    This spike will bring attention to the recovery of this stock very soon.
  • m
    max
    this gonna 🚀 sooon
    Bullish
  • M
    Macrocosmonaut
    OCGN opens higher this week - indicating increasing upward momentum.

    Stock price can explode any time to da moon.

    Watch and learn about stock marcets.

    Do your own due dilligence.

    M.
  • M
    Macrocosmonaut
    8 year old boy is able to see the stars again after gene therapy

    It is fascinating to see how gene therapy of the eye is able to restore the visual function of patients who suffered by retinal inheritated gene related diseases.

    A great story in the field of gene therapy.
    Bullish
  • S
    Son
    Now holding 12 millions shares of this kitty no risk no reward
  • a
    anthony
    Experienced people, what do you all think of occugen? Is it a bust ?
  • M
    Macrocosmonaut
    Retinitis pigmentosa - global patient population 1.5 million

    This means - non regarding AMD marcet and other inherited retinal diseases the valuation of OCGN of the global patient population is only around 35 USD per patient.

    Thats really cheap with sight on the potential genetherapy of around 1 million USD per eye.

    Amazing what an undervaluation.

    Do your own due dilligence.

    M.
    Bullish
  • S
    Son
    PATIENT ☺️
    Bullish
  • H
    Hammer-man
    5yrs ago this was over $200..potential here
    Bullish
  • M
    Macrocosmonaut
    OCGN gap fill at 30 USD per share?

    The chart of OCGN has developed a favourable Long Set Up in the big picture.

    There are two main gaps which should be fillied in future.

    Gap 1 at around 30 USD and the exhaustion gap at around 10 USD per share.

    The upcoming reversal pattern will lead to extraordinary gains and the stock has the potential of 100-bagger at current stock price levels within the first cycle wave up.

    I think the young lady of Cantor Fitzgerald has a good scientific knowledge but no clue about ophtalmology and stockmarcet behaviour.

    This company will enter into a multibillion USD marcet within a few years with high presumability.

    AMD marcet of dry AMD is worth billions of USD per year - and even the wet AMD and Retinitis pigmentosa marcet and other inherited retinal disease will generate billions of USD of revenue over the time - improving the quality of life of affected patients and reducing the costs of the society for blindness.

    A classical win win situation.

    Stock price explosion will occur sooner or later - the longer the positive divergence over time is developing the more impressive will the huge upside cycle structure of this stock.

    I think 10 USD per share is the minimum target within the next months and propably 30 USD and more in the follow up.

    This stock remains a take over target to global pharma player from my point of view.

    Do your own due dilligence.

    M.
    Bullish
  • A
    AL
    Target price went up to .85
    Bullish
  • S
    STEVEN
    Cantor Fitzgerald and Kristen Kluska to Host Zoom Fireside Chat with Ocugen.
  • m
    miguel
    up
  • M
    Mark Nejmeh
    Now holding 1 million shares of this puppy no risk no reward
  • C
    CPRX-ATRS
    1,3m AH after 20min. Cant wait for the news.
  • M
    Macrocosmonaut
    Cantor Fritzgerald Analysts reiterates overweight on Ocugen

    Next week a meeting is planned at Cantor Fitzgerald on OCGN with updates to the current projects.

    Cantor Fritzgerald reiterates its current price target at 1 USD per share
    Bullish